<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Celgene Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Celgene Corporation

    Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Mark J. Alles
    • FOUNDED
      1986
    • EMPLOYEES
      5001-10000
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Innovation Pharmaceuticals Inc.

    Innovation Pharmaceuticals Inc.

    Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pha...

    Established in 2007, and headquartered in Wakef...

    Filing Type:    PU
    Hera Health Solutions, Inc.

    Hera Health Solutions, Inc.

    Hera Health Solutions is a pharmaceutical device company based in Memphis, Tenness...

    Hera Health Solutions is a pharmaceutical devic...

    Amount Raised:    $256,955.00
    Fundraising Status:    SD
    Filing Type:    CF
    Menlo Therapeutics Inc.

    Menlo Therapeutics Inc.

    We are a late stage biopharmaceutical company focused on the development and comme...

    We are a late stage biopharmaceutical company f...

    Filing Type:    PU
    Syneos Health, Inc.

    Syneos Health, Inc.

    Syneos HealthÂŽ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solut...

    Syneos HealthÂŽ (Nasdaq:SYNH) is the only fully...

    Filing Type:    PU
    Mersana Therapeutics, Inc.

    Mersana Therapeutics, Inc.

    Mersana Therapeutics is a clinical-stage biopharmaceutical company using its diffe...

    Mersana Therapeutics is a clinical-stage biopha...

    Filing Type:    PU
    Kala Pharmaceuticals, Inc.

    Kala Pharmaceuticals, Inc.

    Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the de...

    Kala Pharmaceuticals, Inc. (Kala) is a biopharm...

    Filing Type:    PU
    NuCana plc

    NuCana plc

    We are a clinical-stage biopharmaceutical company focused on significantly improvi...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Molecular Templates, Inc.

    Molecular Templates, Inc.

    Molecular Templates is focused on the discovery, development, and commercializatio...

    Molecular Templates is focused on the discovery...

    Filing Type:    PU
    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc. (“Checkpoint”) is a clinical-stage, immuno-oncol...

    Checkpoint Therapeutics, Inc. (“Checkpoint”...

    Filing Type:    PU
    Immunic, Inc.

    Immunic, Inc.

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company develop...

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stag...

    Filing Type:    PU
    Galapagos NV

    Galapagos NV

    Galapagos develops therapies with proprietary, novel modes-of-action. Filgotinib, ...

    Galapagos develops therapies with proprietary, ...

    Filing Type:    PU
    Provention Bio, Inc.

    Provention Bio, Inc.

    Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing nove...

    Provention Bio, Inc. is a clinical-stage biopha...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.